HLF and PPARα axis regulates metabolic-associated fatty liver disease through extracellular vesicles derived from the

Xingzhen Yang1, Jiale Wang1, Xinyu Qi1

  • 1Guangxi Key Laboratory of Animal Breeding, Disease Control and Prevention, College of Animal Science and Technology Guangxi University Nanning China.

Imeta
|April 16, 2025
PubMed

Insights

Hepatic leukemia factor (HLF) in the intestine alleviates metabolic-associated fatty liver disease (MAFLD) by regulating lipid absorption and gut microbiota. This pathway involves extracellular vesicles and taurochenodeoxycholic acid, offering a new therapeutic target for MAFLD.

Area of Science:

  • Gastroenterology and Hepatology
  • Molecular Biology
  • Metabolic Disorders

Background:

  • Metabolic-associated fatty liver disease (MAFLD) prevalence is rising globally.
  • The intestine plays a crucial role in lipid metabolism and homeostasis.
  • Mechanisms linking intestinal function to MAFLD pathogenesis require further elucidation.

Purpose of the Study:

  • To investigate the role of hepatic leukemia factor (HLF) in intestinal lipid absorption and MAFLD development.
  • To identify the molecular pathways and mediators involved in HLF's effect on MAFLD.

Main Methods:

  • Single-cell transcriptome analysis of intestinal tissue from cynomolgus monkeys.
  • Intestine-specific Hlf-knockout mouse models.
  • Lipidomics and functional experiments.

Main Results:

  • HLF regulates intestinal lipid absorption and alleviates intestinal barrier dysfunction by inhibiting PPARα expression.
  • The HLF/PPARα axis modulates gut microbiota-derived extracellular vesicles (fEVs).
  • fEVs containing taurochenodeoxycholic acid (TCDCA) inhibit hepatocyte ferroptosis, ameliorating MAFLD.

Conclusions:

  • Intestinal HLF activity, mediated by fEVs and TCDCA, is a novel mechanism in MAFLD pathogenesis.
  • HLF represents a potential therapeutic target for managing MAFLD.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
460
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
89.1K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
29.9K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K